AustralieFrV1, Main, Curation, bibRecord, 00BF73

Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents

Identifieur interne : 00BF73 ( Main/Curation ); précédent : 00BF72; suivant : 00BF74

Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents

Auteurs : Remi Choussat [France] ; Alexander J. R Black [Australie] ; Irene Bossi [France] ; Thierry Joseph [France] ; Jean Fajadet [France] ; Jean Marco [France]

Source :

Journal of the American College of Cardiology [ 0735-1097 ] ; 2000.

RBID : ISTEX:56909E295E83114B8B70CF521E588C44E5E9E190

Descripteurs français

Pascal (Inist)
- Artère coronaire, Dilatation instrumentale, Endoprothèse, Etude longitudinale, Homme, Homogreffe, Pronostic, Survie, Traitement, Veine saphène.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Abciximab, Abciximab therapy, American college, Angina, Angiographic, Angioplasty, August, Balloon angioplasty, CABG, Cabg, Cardiol, Choussat, Clinical outcome, Coll, Coll cardiol, Consecutive patients, Coronary artery, Diameter stenosis, Distal embolization, Embolization, Endoluminal, Endoluminal reconstruction, Endoprosthesis, Focal lesions, Follow up study, Graft, High incidence, Homograft, Human, Immediate results, Implantation, Infarction, Instrumental dilatation, Jacc, Lesion, Lesion length, MI, Major events, Myocardial infarction, Nontarget, Nontarget vessel, PTCA, Percutaneous, Prognosis, Ptca, Restenosis, Restenosis rate, Revascularization, SVG, Saphenous, Saphenous vein, Saphenous vein graft, Saphenous vein grafts, Saphenous vein grafts jacc, Stable angina, Stenosed, Stenosis, Stent, Stent implantation, Stent site, Stenting, Study patients, Success rate, Survival, Svgs, TIMI, Target lesion, Target vessel, Target vessel revascularization, Thrombus, Ticlopidine, Transluminal, Treatment, Univariate analysis, Unstable angina, Vein graft, Vein grafts, Wallstent, Wallstents.
Teeft :
- Abciximab, Abciximab therapy, American college, Angina, Angiographic, Angioplasty, August, Balloon angioplasty, Cabg, Cardiol, Choussat, Clinical outcome, Coll, Coll cardiol, Consecutive patients, Coronary artery, Diameter stenosis, Distal embolization, Embolization, Endoluminal, Endoluminal reconstruction, Focal lesions, Graft, High incidence, Immediate results, Implantation, Infarction, Jacc, Lesion, Lesion length, Major events, Myocardial infarction, Nontarget, Nontarget vessel, Percutaneous, Ptca, Restenosis, Restenosis rate, Revascularization, Saphenous, Saphenous vein, Saphenous vein graft, Saphenous vein grafts, Saphenous vein grafts jacc, Stable angina, Stenosed, Stenosis, Stent, Stent implantation, Stent site, Stenting, Study patients, Success rate, Svgs, Target lesion, Target vessel, Target vessel revascularization, Thrombus, Ticlopidine, Transluminal, Univariate analysis, Unstable angina, Vein graft, Vein grafts, Wallstent, Wallstents.

Abstract

Abstract: OBJECTIVESThis study was designed to evaluate the immediate and long-term clinical results of patients undergoing endoluminal reconstruction in diffusely degenerated saphenous vein grafts (SVGs) with elective implantation of one or more less-shortening Wallstents.BACKGROUNDThe optimal treatment strategy for patients with diffusely degenerated SVGs is controversial. Endoluminal reconstruction by stent implantation is one proposed strategy; however, there are few data regarding long-term clinical outcome.METHODSBetween May 1995 and September 1998, 6,534 consecutive patients underwent angioplasty in our institution, including 440 who were treated for SVG lesions. Of these, 126 (115 men, 11 women, median age 69.5 years, range: 33–86 years) with old SVGs (mean age: 13 ± 5 years) diffusely degenerated stenosed or occluded (mean lesion length: 27 ± 12 mm) were treated electively with implantation of one or multiple (total 197) less-shortening Wallstents.RESULTSBefore discharge, 13 patients (10.3%) sustained at least one major cardiovascular event, including 4 deaths (3.2%), 11 myocardial infarctions (MI) (8.7%), and 3 repeat revascularizations (target vessel = 1, nontarget vessel = 2, 2.4%). Surviving patients were followed for 22 ± 11 months: 13 patients (11.1%) died, 11 (9.4%) sustained an MI, 37 underwent angioplasty (31.6%), and 4 (3.4%) underwent bypass surgery. The estimated three-year event-free survival rates (freedom from death, and freedom from death/MI/target vessel revascularization) were (mean ± SE) 81.1 ± 7.8% and 43.2 ± 18.5%, respectively.CONCLUSIONSThe long-term clinical outcome of patients undergoing endoluminal reconstruction in diffusely degenerated SVG is relatively poor, mainly because of a high incidence of death or MI and the frequent need for repeat angioplasty. It is unlikely that percutaneous intervention alone will provide a satisfactory or definitive solution for these patients.

Url:

https://api.istex.fr/document/56909E295E83114B8B70CF521E588C44E5E9E190/fulltext/pdf

DOI: 10.1016/S0735-1097(00)00724-5

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001027
to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001027
to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002007
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :00CE86
to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005E58
to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000312
to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :005C27
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :00D175

Links to Exploration step

ISTEX:56909E295E83114B8B70CF521E588C44E5E9E190

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents</title>
<author><name sortKey="Choussat, Remi" sort="Choussat, Remi" uniqKey="Choussat R" first="Remi" last="Choussat">Remi Choussat</name>
</author>
<author><name sortKey="Black, Alexander J R" sort="Black, Alexander J R" uniqKey="Black A" first="Alexander J. R" last="Black">Alexander J. R Black</name>
</author>
<author><name sortKey="Bossi, Irene" sort="Bossi, Irene" uniqKey="Bossi I" first="Irene" last="Bossi">Irene Bossi</name>
</author>
<author><name sortKey="Joseph, Thierry" sort="Joseph, Thierry" uniqKey="Joseph T" first="Thierry" last="Joseph">Thierry Joseph</name>
</author>
<author><name sortKey="Fajadet, Jean" sort="Fajadet, Jean" uniqKey="Fajadet J" first="Jean" last="Fajadet">Jean Fajadet</name>
</author>
<author><name sortKey="Marco, Jean" sort="Marco, Jean" uniqKey="Marco J" first="Jean" last="Marco">Jean Marco</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:56909E295E83114B8B70CF521E588C44E5E9E190</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0735-1097(00)00724-5</idno>
<idno type="url">https://api.istex.fr/document/56909E295E83114B8B70CF521E588C44E5E9E190/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001027</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001027</idno>
<idno type="wicri:Area/Istex/Curation">001027</idno>
<idno type="wicri:Area/Istex/Checkpoint">002007</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002007</idno>
<idno type="wicri:doubleKey">0735-1097:2000:Choussat R:long:term:clinical</idno>
<idno type="wicri:Area/Main/Merge">00CE86</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:00-0395368</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">005E58</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000312</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">005C27</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">005C27</idno>
<idno type="wicri:doubleKey">0735-1097:2000:Choussat R:long:term:clinical</idno>
<idno type="wicri:Area/Main/Merge">00D175</idno>
<idno type="wicri:Area/Main/Curation">00BF73</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents</title>
<author><name sortKey="Choussat, Remi" sort="Choussat, Remi" uniqKey="Choussat R" first="Remi" last="Choussat">Remi Choussat</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Black, Alexander J R" sort="Black, Alexander J R" uniqKey="Black A" first="Alexander J. R" last="Black">Alexander J. R Black</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Cardiology, The Geelong Hospital, Geelong</wicri:regionArea>
<wicri:noRegion>Geelong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bossi, Irene" sort="Bossi, Irene" uniqKey="Bossi I" first="Irene" last="Bossi">Irene Bossi</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Joseph, Thierry" sort="Joseph, Thierry" uniqKey="Joseph T" first="Thierry" last="Joseph">Thierry Joseph</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fajadet, Jean" sort="Fajadet, Jean" uniqKey="Fajadet J" first="Jean" last="Fajadet">Jean Fajadet</name>
<affiliation></affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marco, Jean" sort="Marco, Jean" uniqKey="Marco J" first="Jean" last="Marco">Jean Marco</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of the American College of Cardiology</title>
<title level="j" type="abbrev">JAC</title>
<idno type="ISSN">0735-1097</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">36</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="387">387</biblScope>
<biblScope unit="page" to="394">394</biblScope>
</imprint>
<idno type="ISSN">0735-1097</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0735-1097</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abciximab</term>
<term>Abciximab therapy</term>
<term>American college</term>
<term>Angina</term>
<term>Angiographic</term>
<term>Angioplasty</term>
<term>August</term>
<term>Balloon angioplasty</term>
<term>CABG</term>
<term>Cabg</term>
<term>Cardiol</term>
<term>Choussat</term>
<term>Clinical outcome</term>
<term>Coll</term>
<term>Coll cardiol</term>
<term>Consecutive patients</term>
<term>Coronary artery</term>
<term>Diameter stenosis</term>
<term>Distal embolization</term>
<term>Embolization</term>
<term>Endoluminal</term>
<term>Endoluminal reconstruction</term>
<term>Endoprosthesis</term>
<term>Focal lesions</term>
<term>Follow up study</term>
<term>Graft</term>
<term>High incidence</term>
<term>Homograft</term>
<term>Human</term>
<term>Immediate results</term>
<term>Implantation</term>
<term>Infarction</term>
<term>Instrumental dilatation</term>
<term>Jacc</term>
<term>Lesion</term>
<term>Lesion length</term>
<term>MI</term>
<term>Major events</term>
<term>Myocardial infarction</term>
<term>Nontarget</term>
<term>Nontarget vessel</term>
<term>PTCA</term>
<term>Percutaneous</term>
<term>Prognosis</term>
<term>Ptca</term>
<term>Restenosis</term>
<term>Restenosis rate</term>
<term>Revascularization</term>
<term>SVG</term>
<term>Saphenous</term>
<term>Saphenous vein</term>
<term>Saphenous vein graft</term>
<term>Saphenous vein grafts</term>
<term>Saphenous vein grafts jacc</term>
<term>Stable angina</term>
<term>Stenosed</term>
<term>Stenosis</term>
<term>Stent</term>
<term>Stent implantation</term>
<term>Stent site</term>
<term>Stenting</term>
<term>Study patients</term>
<term>Success rate</term>
<term>Survival</term>
<term>Svgs</term>
<term>TIMI</term>
<term>Target lesion</term>
<term>Target vessel</term>
<term>Target vessel revascularization</term>
<term>Thrombus</term>
<term>Ticlopidine</term>
<term>Transluminal</term>
<term>Treatment</term>
<term>Univariate analysis</term>
<term>Unstable angina</term>
<term>Vein graft</term>
<term>Vein grafts</term>
<term>Wallstent</term>
<term>Wallstents</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Artère coronaire</term>
<term>Dilatation instrumentale</term>
<term>Endoprothèse</term>
<term>Etude longitudinale</term>
<term>Homme</term>
<term>Homogreffe</term>
<term>Pronostic</term>
<term>Survie</term>
<term>Traitement</term>
<term>Veine saphène</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abciximab</term>
<term>Abciximab therapy</term>
<term>American college</term>
<term>Angina</term>
<term>Angiographic</term>
<term>Angioplasty</term>
<term>August</term>
<term>Balloon angioplasty</term>
<term>Cabg</term>
<term>Cardiol</term>
<term>Choussat</term>
<term>Clinical outcome</term>
<term>Coll</term>
<term>Coll cardiol</term>
<term>Consecutive patients</term>
<term>Coronary artery</term>
<term>Diameter stenosis</term>
<term>Distal embolization</term>
<term>Embolization</term>
<term>Endoluminal</term>
<term>Endoluminal reconstruction</term>
<term>Focal lesions</term>
<term>Graft</term>
<term>High incidence</term>
<term>Immediate results</term>
<term>Implantation</term>
<term>Infarction</term>
<term>Jacc</term>
<term>Lesion</term>
<term>Lesion length</term>
<term>Major events</term>
<term>Myocardial infarction</term>
<term>Nontarget</term>
<term>Nontarget vessel</term>
<term>Percutaneous</term>
<term>Ptca</term>
<term>Restenosis</term>
<term>Restenosis rate</term>
<term>Revascularization</term>
<term>Saphenous</term>
<term>Saphenous vein</term>
<term>Saphenous vein graft</term>
<term>Saphenous vein grafts</term>
<term>Saphenous vein grafts jacc</term>
<term>Stable angina</term>
<term>Stenosed</term>
<term>Stenosis</term>
<term>Stent</term>
<term>Stent implantation</term>
<term>Stent site</term>
<term>Stenting</term>
<term>Study patients</term>
<term>Success rate</term>
<term>Svgs</term>
<term>Target lesion</term>
<term>Target vessel</term>
<term>Target vessel revascularization</term>
<term>Thrombus</term>
<term>Ticlopidine</term>
<term>Transluminal</term>
<term>Univariate analysis</term>
<term>Unstable angina</term>
<term>Vein graft</term>
<term>Vein grafts</term>
<term>Wallstent</term>
<term>Wallstents</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: OBJECTIVESThis study was designed to evaluate the immediate and long-term clinical results of patients undergoing endoluminal reconstruction in diffusely degenerated saphenous vein grafts (SVGs) with elective implantation of one or more less-shortening Wallstents.BACKGROUNDThe optimal treatment strategy for patients with diffusely degenerated SVGs is controversial. Endoluminal reconstruction by stent implantation is one proposed strategy; however, there are few data regarding long-term clinical outcome.METHODSBetween May 1995 and September 1998, 6,534 consecutive patients underwent angioplasty in our institution, including 440 who were treated for SVG lesions. Of these, 126 (115 men, 11 women, median age 69.5 years, range: 33–86 years) with old SVGs (mean age: 13 ± 5 years) diffusely degenerated stenosed or occluded (mean lesion length: 27 ± 12 mm) were treated electively with implantation of one or multiple (total 197) less-shortening Wallstents.RESULTSBefore discharge, 13 patients (10.3%) sustained at least one major cardiovascular event, including 4 deaths (3.2%), 11 myocardial infarctions (MI) (8.7%), and 3 repeat revascularizations (target vessel = 1, nontarget vessel = 2, 2.4%). Surviving patients were followed for 22 ± 11 months: 13 patients (11.1%) died, 11 (9.4%) sustained an MI, 37 underwent angioplasty (31.6%), and 4 (3.4%) underwent bypass surgery. The estimated three-year event-free survival rates (freedom from death, and freedom from death/MI/target vessel revascularization) were (mean ± SE) 81.1 ± 7.8% and 43.2 ± 18.5%, respectively.CONCLUSIONSThe long-term clinical outcome of patients undergoing endoluminal reconstruction in diffusely degenerated SVG is relatively poor, mainly because of a high incidence of death or MI and the frequent need for repeat angioplasty. It is unlikely that percutaneous intervention alone will provide a satisfactory or definitive solution for these patients.</div>
</front>
</TEI>
<double idat="0735-1097:2000:Choussat R:long:term:clinical"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents</title>
<author><name sortKey="Choussat, R" sort="Choussat, R" uniqKey="Choussat R" first="R." last="Choussat">R. Choussat</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Black, A J R" sort="Black, A J R" uniqKey="Black A" first="A. J. R." last="Black">A. J. R. Black</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Cardiology, The Geelong Hospital</s1>
<s2>Geelong</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Geelong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bossi, I" sort="Bossi, I" uniqKey="Bossi I" first="I." last="Bossi">I. Bossi</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Joseph, T" sort="Joseph, T" uniqKey="Joseph T" first="T." last="Joseph">T. Joseph</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fajadet, J" sort="Fajadet, J" uniqKey="Fajadet J" first="J." last="Fajadet">J. Fajadet</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marco, J" sort="Marco, J" uniqKey="Marco J" first="J." last="Marco">J. Marco</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0395368</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0395368 INIST</idno>
<idno type="RBID">Pascal:00-0395368</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">005E58</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000312</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">005C27</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">005C27</idno>
<idno type="wicri:doubleKey">0735-1097:2000:Choussat R:long:term:clinical</idno>
<idno type="wicri:Area/Main/Merge">00D175</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents</title>
<author><name sortKey="Choussat, R" sort="Choussat, R" uniqKey="Choussat R" first="R." last="Choussat">R. Choussat</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Black, A J R" sort="Black, A J R" uniqKey="Black A" first="A. J. R." last="Black">A. J. R. Black</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Cardiology, The Geelong Hospital</s1>
<s2>Geelong</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Geelong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bossi, I" sort="Bossi, I" uniqKey="Bossi I" first="I." last="Bossi">I. Bossi</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Joseph, T" sort="Joseph, T" uniqKey="Joseph T" first="T." last="Joseph">T. Joseph</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fajadet, J" sort="Fajadet, J" uniqKey="Fajadet J" first="J." last="Fajadet">J. Fajadet</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marco, J" sort="Marco, J" uniqKey="Marco J" first="J." last="Marco">J. Marco</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Cardiologie Interventionelle, Clinique Pasteur</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of the American College of Cardiology</title>
<title level="j" type="abbreviated">J. Am. Coll. Cardiol.</title>
<idno type="ISSN">0735-1097</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of the American College of Cardiology</title>
<title level="j" type="abbreviated">J. Am. Coll. Cardiol.</title>
<idno type="ISSN">0735-1097</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coronary artery</term>
<term>Endoprosthesis</term>
<term>Follow up study</term>
<term>Homograft</term>
<term>Human</term>
<term>Instrumental dilatation</term>
<term>Prognosis</term>
<term>Saphenous vein</term>
<term>Survival</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dilatation instrumentale</term>
<term>Artère coronaire</term>
<term>Homogreffe</term>
<term>Veine saphène</term>
<term>Endoprothèse</term>
<term>Etude longitudinale</term>
<term>Traitement</term>
<term>Pronostic</term>
<term>Survie</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">OBJECTIVES This study was designed to evaluate the immediate and long-term clinical results of patients undergoing endoluminal reconstruction in diffusely degenerated saphenous vein grafts (SVGs) with elective implantation of one or more less-shortening Wallstents. BACKGROUND The optimal treatment strategy for patients with diffusely degenerated SVGs is controversial. Endoluminal reconstruction by stent implantation is one proposed strategy; however, there are few data regarding long-term clinical outcome. METHODS Between May 1995 and September 1998, 6,534 consecutive patients underwent angioplasty in our institution, including 440 who were treated for SVG lesions. Of these, 126 (115 men, 11 women, median age 69.5 years, range: 33-86 years) with old SVGs (mean age: 13 ± 5 years) diffusely degenerated stenosed or occluded (mean lesion length: 27 ± 12 mm) were treated electively with implantation of one or multiple (total 197) less-shortening Wallstents. RESULTS Before discharge, 13 patients (10.3%) sustained at least one major cardiovascular event, including 4 deaths (3.2%), 11 myocardial infarctions (MI) (8.7%), and 3 repeat revascularizations (target vessel = 1, nontarget vessel = 2, 2.4%). Surviving patients were followed for 22 ± 11 months: 13 patients (11.1%) died, 11 (9.4%) sustained an MI, 37 underwent angioplasty (31.6%), and 4 (3.4%) underwent bypass surgery. The estimated three-year event-free survival rates (freedom from death, and freedom from death/MI/target vessel revascularization) were (mean ± SE) 81.1 ± 7.8% and 43.2 ± 18.5%, respectively. CONCLUSIONS The long-term clinical outcome of patients undergoing endoluminal reconstruction in diffusely degenerated SVG is relatively poor, mainly because of a high incidence of death or MI and the frequent need for repeat angioplasty. It is unlikely that percutaneous intervention alone will provide a satisfactory or definitive solution for these patients.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents</title>
<author><name sortKey="Choussat, Remi" sort="Choussat, Remi" uniqKey="Choussat R" first="Remi" last="Choussat">Remi Choussat</name>
</author>
<author><name sortKey="Black, Alexander J R" sort="Black, Alexander J R" uniqKey="Black A" first="Alexander J. R" last="Black">Alexander J. R Black</name>
</author>
<author><name sortKey="Bossi, Irene" sort="Bossi, Irene" uniqKey="Bossi I" first="Irene" last="Bossi">Irene Bossi</name>
</author>
<author><name sortKey="Joseph, Thierry" sort="Joseph, Thierry" uniqKey="Joseph T" first="Thierry" last="Joseph">Thierry Joseph</name>
</author>
<author><name sortKey="Fajadet, Jean" sort="Fajadet, Jean" uniqKey="Fajadet J" first="Jean" last="Fajadet">Jean Fajadet</name>
</author>
<author><name sortKey="Marco, Jean" sort="Marco, Jean" uniqKey="Marco J" first="Jean" last="Marco">Jean Marco</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:56909E295E83114B8B70CF521E588C44E5E9E190</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0735-1097(00)00724-5</idno>
<idno type="url">https://api.istex.fr/document/56909E295E83114B8B70CF521E588C44E5E9E190/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001027</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001027</idno>
<idno type="wicri:Area/Istex/Curation">001027</idno>
<idno type="wicri:Area/Istex/Checkpoint">002007</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002007</idno>
<idno type="wicri:doubleKey">0735-1097:2000:Choussat R:long:term:clinical</idno>
<idno type="wicri:Area/Main/Merge">00CE86</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents</title>
<author><name sortKey="Choussat, Remi" sort="Choussat, Remi" uniqKey="Choussat R" first="Remi" last="Choussat">Remi Choussat</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Black, Alexander J R" sort="Black, Alexander J R" uniqKey="Black A" first="Alexander J. R" last="Black">Alexander J. R Black</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Cardiology, The Geelong Hospital, Geelong</wicri:regionArea>
<wicri:noRegion>Geelong</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bossi, Irene" sort="Bossi, Irene" uniqKey="Bossi I" first="Irene" last="Bossi">Irene Bossi</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Joseph, Thierry" sort="Joseph, Thierry" uniqKey="Joseph T" first="Thierry" last="Joseph">Thierry Joseph</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fajadet, Jean" sort="Fajadet, Jean" uniqKey="Fajadet J" first="Jean" last="Fajadet">Jean Fajadet</name>
<affiliation></affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marco, Jean" sort="Marco, Jean" uniqKey="Marco J" first="Jean" last="Marco">Jean Marco</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of the American College of Cardiology</title>
<title level="j" type="abbrev">JAC</title>
<idno type="ISSN">0735-1097</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">36</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="387">387</biblScope>
<biblScope unit="page" to="394">394</biblScope>
</imprint>
<idno type="ISSN">0735-1097</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0735-1097</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abciximab</term>
<term>Abciximab therapy</term>
<term>American college</term>
<term>Angina</term>
<term>Angiographic</term>
<term>Angioplasty</term>
<term>August</term>
<term>Balloon angioplasty</term>
<term>CABG</term>
<term>Cabg</term>
<term>Cardiol</term>
<term>Choussat</term>
<term>Clinical outcome</term>
<term>Coll</term>
<term>Coll cardiol</term>
<term>Consecutive patients</term>
<term>Coronary artery</term>
<term>Diameter stenosis</term>
<term>Distal embolization</term>
<term>Embolization</term>
<term>Endoluminal</term>
<term>Endoluminal reconstruction</term>
<term>Focal lesions</term>
<term>Graft</term>
<term>High incidence</term>
<term>Immediate results</term>
<term>Implantation</term>
<term>Infarction</term>
<term>Jacc</term>
<term>Lesion</term>
<term>Lesion length</term>
<term>MI</term>
<term>Major events</term>
<term>Myocardial infarction</term>
<term>Nontarget</term>
<term>Nontarget vessel</term>
<term>PTCA</term>
<term>Percutaneous</term>
<term>Ptca</term>
<term>Restenosis</term>
<term>Restenosis rate</term>
<term>Revascularization</term>
<term>SVG</term>
<term>Saphenous</term>
<term>Saphenous vein</term>
<term>Saphenous vein graft</term>
<term>Saphenous vein grafts</term>
<term>Saphenous vein grafts jacc</term>
<term>Stable angina</term>
<term>Stenosed</term>
<term>Stenosis</term>
<term>Stent</term>
<term>Stent implantation</term>
<term>Stent site</term>
<term>Stenting</term>
<term>Study patients</term>
<term>Success rate</term>
<term>Svgs</term>
<term>TIMI</term>
<term>Target lesion</term>
<term>Target vessel</term>
<term>Target vessel revascularization</term>
<term>Thrombus</term>
<term>Ticlopidine</term>
<term>Transluminal</term>
<term>Univariate analysis</term>
<term>Unstable angina</term>
<term>Vein graft</term>
<term>Vein grafts</term>
<term>Wallstent</term>
<term>Wallstents</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abciximab</term>
<term>Abciximab therapy</term>
<term>American college</term>
<term>Angina</term>
<term>Angiographic</term>
<term>Angioplasty</term>
<term>August</term>
<term>Balloon angioplasty</term>
<term>Cabg</term>
<term>Cardiol</term>
<term>Choussat</term>
<term>Clinical outcome</term>
<term>Coll</term>
<term>Coll cardiol</term>
<term>Consecutive patients</term>
<term>Coronary artery</term>
<term>Diameter stenosis</term>
<term>Distal embolization</term>
<term>Embolization</term>
<term>Endoluminal</term>
<term>Endoluminal reconstruction</term>
<term>Focal lesions</term>
<term>Graft</term>
<term>High incidence</term>
<term>Immediate results</term>
<term>Implantation</term>
<term>Infarction</term>
<term>Jacc</term>
<term>Lesion</term>
<term>Lesion length</term>
<term>Major events</term>
<term>Myocardial infarction</term>
<term>Nontarget</term>
<term>Nontarget vessel</term>
<term>Percutaneous</term>
<term>Ptca</term>
<term>Restenosis</term>
<term>Restenosis rate</term>
<term>Revascularization</term>
<term>Saphenous</term>
<term>Saphenous vein</term>
<term>Saphenous vein graft</term>
<term>Saphenous vein grafts</term>
<term>Saphenous vein grafts jacc</term>
<term>Stable angina</term>
<term>Stenosed</term>
<term>Stenosis</term>
<term>Stent</term>
<term>Stent implantation</term>
<term>Stent site</term>
<term>Stenting</term>
<term>Study patients</term>
<term>Success rate</term>
<term>Svgs</term>
<term>Target lesion</term>
<term>Target vessel</term>
<term>Target vessel revascularization</term>
<term>Thrombus</term>
<term>Ticlopidine</term>
<term>Transluminal</term>
<term>Univariate analysis</term>
<term>Unstable angina</term>
<term>Vein graft</term>
<term>Vein grafts</term>
<term>Wallstent</term>
<term>Wallstents</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: OBJECTIVESThis study was designed to evaluate the immediate and long-term clinical results of patients undergoing endoluminal reconstruction in diffusely degenerated saphenous vein grafts (SVGs) with elective implantation of one or more less-shortening Wallstents.BACKGROUNDThe optimal treatment strategy for patients with diffusely degenerated SVGs is controversial. Endoluminal reconstruction by stent implantation is one proposed strategy; however, there are few data regarding long-term clinical outcome.METHODSBetween May 1995 and September 1998, 6,534 consecutive patients underwent angioplasty in our institution, including 440 who were treated for SVG lesions. Of these, 126 (115 men, 11 women, median age 69.5 years, range: 33–86 years) with old SVGs (mean age: 13 ± 5 years) diffusely degenerated stenosed or occluded (mean lesion length: 27 ± 12 mm) were treated electively with implantation of one or multiple (total 197) less-shortening Wallstents.RESULTSBefore discharge, 13 patients (10.3%) sustained at least one major cardiovascular event, including 4 deaths (3.2%), 11 myocardial infarctions (MI) (8.7%), and 3 repeat revascularizations (target vessel = 1, nontarget vessel = 2, 2.4%). Surviving patients were followed for 22 ± 11 months: 13 patients (11.1%) died, 11 (9.4%) sustained an MI, 37 underwent angioplasty (31.6%), and 4 (3.4%) underwent bypass surgery. The estimated three-year event-free survival rates (freedom from death, and freedom from death/MI/target vessel revascularization) were (mean ± SE) 81.1 ± 7.8% and 43.2 ± 18.5%, respectively.CONCLUSIONSThe long-term clinical outcome of patients undergoing endoluminal reconstruction in diffusely degenerated SVG is relatively poor, mainly because of a high incidence of death or MI and the frequent need for repeat angioplasty. It is unlikely that percutaneous intervention alone will provide a satisfactory or definitive solution for these patients.</div>
</front>
</TEI>
</ISTEX>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00BF73 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 00BF73 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:56909E295E83114B8B70CF521E588C44E5E9E190
   |texte=   Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents

Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri